Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Agenus Inc
AGEN
Healthcare
Biotechnology
Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its...
primary focus is I-O, and its diverse pipeline is supported by its in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. Its most advanced antibody candidates are botensilimab (a multifunctional immune cell activator and human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody (AGEN1811)) and balstilimab (a programmed death receptor-1 (PD-1) blocking antibody). Its pipeline includes several classes of immunotherapies: checkpoint inhibitors, immune activators, and tumor microenvironment conditioning agents.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:AGEN)
New Post
View:
Posts & Comments
Threaded Posts
(98)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on May 07, 2024 11:45pm
Agenus (AGEN) Q1 2024 Earnings Call Transcript
BREAKING NEWS: $AGEN Agenus (AGEN) Q1 2024 Earnings Call Transcript2024-05-07 17:45:24 ET Image source: The Motley Fool. Agenus (NASDAQ: AGEN) Q1 2024 Earnings Call May 07, 2024 , 8:30 a.m. ET
...more
(98)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on May 07, 2024 11:30pm
Agenus Reports First Quarter 2024 Results
Just In: $AGEN Agenus Reports First Quarter 2024 Results$100M royalty financing agreement with Ligand announced, bringing in capital via non-equity means to support critical botensilimab/balstilimab
...more
(4)
•••
zalmonella
X
View Profile
View Bullboard History
Post by
zalmonella
on Apr 26, 2024 6:03pm
No(w) Fun City?
Is there a short squeeze on? No news, up 40% in a day. After the 20:1 consolidation, there were 21 million share outstanding an 2.5M short. The daily volume wasn't near enough to make that
...more
(98)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 23, 2024 11:45am
Top 2 Health Care Stocks Which Could Rescue Your Portfolio T
News; $AGEN Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month | BenzingaThe most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies
...more
(4)
•••
zalmonella
X
View Profile
View Bullboard History
Post by
zalmonella
on Apr 08, 2024 11:42pm
No fun city
Great. One April 13 i will have 250 shares of this worthless stock for which I've paid over the years a total of $10,400. I'm not counting on seeing $42 a share anytime soon. Hit
...more
(61)
•••
Nibinator
X
View Profile
View Bullboard History
Post by
Nibinator
on Mar 31, 2024 9:14pm
BUY BUY BUY BUY BUY
I will make this my third transaction tomorow
(4)
•••
zalmonella
X
View Profile
View Bullboard History
Post by
zalmonella
on Feb 15, 2024 2:35pm
Reverse split
Now this morning a reverse split (8K) proposed at 1:20.
(98)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jan 31, 2024 12:15pm
Agenus to Participate in Oppenheimer 34th Annual Healthcare
Breaking News: $AGEN Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences ConferenceAgenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and
...more
(4)
•••
zalmonella
X
View Profile
View Bullboard History
Post by
zalmonella
on Jan 12, 2024 4:36pm
Waht's the opposite of a "New Year's rally"?
Hmmmm... Big volume last few days and serious drop in price. shot interest at month end was around 16%, there are indications that's come down a bit. wonder what's goping on? They
...more
(4)
•••
zalmonella
X
View Profile
View Bullboard History
Post by
zalmonella
on Oct 24, 2023 4:21pm
New data on the weekend
Phew! Nnobody likes good news. Not that it was very good news, but at least it wasn't a prime fail. Surprised to see it fall off 20% in the last few days.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
Xcyte Digital Corp. Releases "Xperience" Subscription Service